Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky".

Clin Vaccine Immunol

Development Department, Vaccine Division, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), Kita-ku Kumamoto-shi, Kumamoto, Japan.

Published: May 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412934PMC
http://dx.doi.org/10.1128/CVI.00055-15DOI Listing

Publication Analysis

Top Keywords

reply "use
4
"use lc16m8
4
lc16m8 smallpox
4
smallpox vaccine
4
vaccine immunocompromised
4
immunocompromised individuals
4
individuals risky"
4
reply
1
lc16m8
1
smallpox
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!